These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15553322)

  • 1. [Evaluation of methadone dispensing in Belgium--study synopsis].
    Ledoux Y
    J Pharm Belg; 2004; 59(3):69-79. PubMed ID: 15553322
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.
    Madden A; Lea T; Bath N; Winstock AR
    Drug Alcohol Rev; 2008 Nov; 27(6):671-8. PubMed ID: 19378450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicians practicing in methadone treatment programs: who are they and what do they do?
    Wechsberg WM; Flannery B; Kasten JJ; Suerken C; Dunlap L; Roussel AE; Crum L; Murdoch O; Diesenhaus H
    J Addict Dis; 2004; 23(2):15-31. PubMed ID: 15132340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supervised methadone consumption: client issues and stigma.
    Anstice S; Strike CJ; Brands B
    Subst Use Misuse; 2009; 44(6):794-808. PubMed ID: 19444722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological correlates of methadone maintenance pharmacotherapy.
    Kreek MJ
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():9-14. PubMed ID: 7880038
    [No Abstract]   [Full Text] [Related]  

  • 10. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
    Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B
    Am J Drug Alcohol Abuse; 2007; 33(5):665-74. PubMed ID: 17891659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey.
    Judson G; Bird R; O'Connor P; Bevin T; Loan R; Schroder M; McGrath R; Weatherall M; Moriarty H; Robinson G
    Drug Alcohol Rev; 2010 Jan; 29(1):41-6. PubMed ID: 20078681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating opioid dependence.
    Reese TV
    N Engl J Med; 2001 Feb; 344(7):530; author reply 530-1. PubMed ID: 11221619
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment.
    Dobler-Mikola A; Hättenschwiler J; Meili D; Beck T; Böni E; Modestin J
    J Subst Abuse Treat; 2005 Dec; 29(4):259-65. PubMed ID: 16311178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients.
    Peles E; Kreek MJ; Kellogg S; Adelson M
    J Addict Dis; 2006; 25(1):43-50. PubMed ID: 16597572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divided doses for methadone maintenance.
    Adinoff B
    Am J Psychiatry; 2008 Mar; 165(3):303-5. PubMed ID: 18316426
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rational control analysis within the scope of a methadone program].
    Wehinger G; Battista HJ
    Beitr Gerichtl Med; 1990; 48():703-11. PubMed ID: 2241862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.